Live Breaking News & Updates on Myrisk hereditary cancer test

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Matt-scalo , Shelly-cummings , Oncology-medical-affairs , Exchange-commission , Vice-president , Medical-affairs , Myrisk-hereditary-cancer-test , Private-securities-litigation-reform-act , Annual-report , Quarterly-reports , Current-reports ,

1900 Wealth Management LLC Buys New Position in Myriad Genetics, Inc. (NASDAQ:MYGN)

1900 Wealth Management LLC Buys New Position in Myriad Genetics, Inc. (NASDAQ:MYGN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Hong-kong , Richard-bryan-riggsbee , Piper-sandler , Tower-research-capital , Royal-bank , Wolfe-research , Nasdaq , Genetics-inc , Wealth-management , Jpmorgan-chase-co

Myriad Genetics (NASDAQ:MYGN) Earns Neutral Rating from Analysts at Piper Sandler

Piper Sandler initiated coverage on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm issued a neutral rating and a $23.00 price target on the stock. A number of other analysts have also weighed in on MYGN. StockNews.com upgraded shares of Myriad Genetics from […]

China , Canada , Hong-kong , United-states , Richard-bryan-riggsbee , Piper-sandler , Royal-bank , Wolfe-research , Hong-kong-ltd , Securities-exchange-commission , China-universal-asset-management-co , Tower-research-capital

Myriad Genetics (NASDAQ:MYGN) Releases FY 2023 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of -0.330–0.280 for the period, compared to the consensus EPS estimate of -0.300. The company issued revenue guidance of $747.0 million-$753.0 million, compared to the consensus revenue estimate of $750.9 million. […]

Canada , Hong-kong , United-states , Richard-bryan-riggsbee , Piper-sandler , Wells-fargo-company , Royal-bank , Tower-research-capital , Genetics-inc , Jpmorgan-chase-co , Hong-kong-ltd , Wolfe-research

Myriad Genetics (NASDAQ:MYGN) Earns Equal Weight Rating from Analysts at Wells Fargo & Company

Myriad Genetics (NASDAQ:MYGN) Earns Equal Weight Rating from Analysts at Wells Fargo & Company
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , China , United-states , Canada , Richard-bryan-riggsbee , China-universal-asset-management-co , Genetics-company-profile , Wolfe-research , Royal-bank , Securities-exchange-commission , Wells-fargo-company , Genetics-inc